Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...

(HealthDay News) — Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes, according to a study published ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

In the benign cohort, initial biopsies showed 37% of patients had ASAP with or without high-grade prostatic intraepithelial neoplasia (HGPIN), while 28% had HGPIN only, and 52% had neither ASAP or ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

(HealthDay News) — There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups, according to a study published online in the ...

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.